ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,225.33
-0.27%
Dow Jones
39,133.89
0.06%
Gold vs US Dollar
2,300.58
-0.87%
Brent Oil
84.445
0.31%
Bitcoin
61,495.82
-0.51%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Eisai Company Ltd (PK) (ESALY)

  7. Eisai Company Ltd (PK) (ESALY) News

Eisai (PK) (ESALY)

Eisai Company Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ESALY
DateTimeSourceHeadlineSymbolCompany
09/01/202316:01Dow Jones NewsTrending: Biogen, Eisai Win FDA Nod for Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
06/01/202322:20Dow Jones NewsADRs End Higher, Shell and Eisai Trade ActivelyUSOTC:ESALYEisai Company Ltd (PK)
30/11/202215:46Dow Jones NewsTrending: Eisai/Biogen Alzheimer's Drug Shows Positive ResultsUSOTC:ESALYEisai Company Ltd (PK)
30/11/202211:05TipRanksBiogen and Eisai’s Alzheimer’s Drug May Pose Serious Risks, Say ResearchersUSOTC:ESALYEisai Company Ltd (PK)
28/09/202218:45Dow Jones NewsDrug Companies Pursuing Alzheimer Treatments See Shares Rise WednesdayUSOTC:ESALYEisai Company Ltd (PK)
28/09/202203:05Dow Jones NewsEisai Shares Indicated Sharply Higher After Trial of Experimental Drug Slows Alzheimer's ProgressionUSOTC:ESALYEisai Company Ltd (PK)
03/08/202212:48Dow Jones NewsMerck: Two Phase 3 Keytruda Studies Miss TargetsUSOTC:ESALYEisai Company Ltd (PK)
06/07/202204:05Dow Jones NewsEisai Shares Rise Sharply After U.S. FDA Grants Priority Review for Potential Alzheimer's DrugUSOTC:ESALYEisai Company Ltd (PK)
23/12/202103:27Dow Jones NewsEisai Shares Fall Sharply After Japan Panel Seeks More Data for Aduhelm ReviewUSOTC:ESALYEisai Company Ltd (PK)
22/12/202113:26Dow Jones NewsBiogen: Japan Panel Seeks Additional Data in Aducanumab ReviewUSOTC:ESALYEisai Company Ltd (PK)
17/12/202113:00Dow Jones NewsBiogen's Alzheimer's Treatment Gets Negative CHMP OpinionUSOTC:ESALYEisai Company Ltd (PK)
29/11/202112:28Dow Jones NewsMerck, Eisai Get Europe OK for Lenvima/Keytruda Combination in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
11/11/202123:40Dow Jones NewsBiogen, Eisai Alzheimer Treatment Shows Positive Signs in Advanced TrialUSOTC:ESALYEisai Company Ltd (PK)
15/10/202113:21Dow Jones NewsMerck, Eisai Get CHMP Backing for Lenvima-Keytruda Combo in Two CancersUSOTC:ESALYEisai Company Ltd (PK)
28/01/201622:00Dow Jones NewsFDA Approves Eisai's Halaven to Treat LiposarcomaUSOTC:ESALYEisai Company Ltd (PK)
02/09/201507:00Dow Jones NewsAmgen to Help Develop Novartis's Pipeline of Alzheimer's DrugsUSOTC:ESALYEisai Company Ltd (PK)
09/06/201516:06The Motley FoolObesity Drugs: Stocks to WatchUSOTC:ESALYEisai Company Ltd (PK)
10/04/201500:20Dow Jones NewsJapanese Drug Company Eisai to Cut 25% of U.S. JobsUSOTC:ESALYEisai Company Ltd (PK)
28/03/201516:03The Motley Fool5 Freakishly Expensive Cancer DrugsUSOTC:ESALYEisai Company Ltd (PK)
11/09/201413:50Dow Jones NewsFDA Approves Orexigen's Diet Drug ContraveUSOTC:ESALYEisai Company Ltd (PK)
16/12/201322:05ZacksPipeline Progress at Corcept - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
08/11/201322:00ZacksArena Pharma Q3 Loss Narrower than Expected - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
17/06/201303:53Dow Jones NewsASIA MARKETS: Japan Stocks Rebound As Asia Awaits Fed MeetingUSOTC:ESALYEisai Company Ltd (PK)
14/05/201311:02ZacksJazz Pharma Posts Higher Y/Y Earnings - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
06/05/201312:10ZacksArena Pharma Narrows Loss - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
23/04/201318:45ZacksData from Novartis' SPARK - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
16/04/201319:30ZacksBioLineRx to Start BL-8040 Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
16/04/201319:30ZacksBioLineRx to Start BL-8040 Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
09/04/201318:55ZacksPatients Dosed in Arena Study - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
08/03/201314:43ZacksArena Cuts Loss, Misses Estimates - Analyst BlogUSOTC:ESALYEisai Company Ltd (PK)
 Showing the most relevant articles for your search:USOTC:ESALY

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
POS
Plexus
LSE
EEE
Empire Metals
LSE
GKP
Gulf Keystone Petroleum
LSE
PHNX
Phoenix
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
ENET
Ethernity Networks
LSE
ALTN
Altyngold
LSE
TERN
Tern
LSE
THG
Thg
LSE
AAU
Ariana Resources
LSE
GDR
Genedrive
LSE
TW.
Taylor Wimpey
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved